Report Detail
Global Everolimus Eluting Stent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4661452 |
- 31 December, 2025 |
- Global |
- 83 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Everolimus Eluting Stent market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Ivolimus drug eluting stents are typically composed of a metal scaffold and a drug coating covering the surface of the scaffold. Metal brackets are usually made of biocompatible materials, such as stainless steel, chromium cobalt alloy, etc. The drug coating of the stent contains Everolimus, an immunosuppressive drug. The drug will be released onto the vascular wall around the stent, thereby inhibiting intimal hyperplasia and reducing the risk of vascular restenosis. Ivolimus drug eluting stents work in two ways: metal stents provide mechanical support to maintain vascular patency; The drug coating releases everolimus, inhibits vascular intimal hyperplasia, and reduces the possibility of vascular restenosis.
This report is a detailed and comprehensive analysis for global Everolimus Eluting Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Everolimus Eluting Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Everolimus Eluting Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Everolimus Eluting Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Everolimus Eluting Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Everolimus Eluting Stent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Everolimus Eluting Stent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Everolimus Eluting Stent market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PLGA Polymer Coating
Fluoropolymer Coating
Market segment by Application
Hospital
Clinic
Others
Major players covered
Boston Scientific
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Everolimus Eluting Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Everolimus Eluting Stent, with price, sales quantity, revenue, and global market share of Everolimus Eluting Stent from 2020 to 2025.
Chapter 3, the Everolimus Eluting Stent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Everolimus Eluting Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Everolimus Eluting Stent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Everolimus Eluting Stent.
Chapter 14 and 15, to describe Everolimus Eluting Stent sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Everolimus Eluting Stent Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 PLGA Polymer Coating
- 1.3.3 Fluoropolymer Coating
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Everolimus Eluting Stent Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Everolimus Eluting Stent Market Size & Forecast
- 1.5.1 Global Everolimus Eluting Stent Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Everolimus Eluting Stent Sales Quantity (2020-2031)
- 1.5.3 Global Everolimus Eluting Stent Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Boston Scientific
- 2.1.1 Boston Scientific Details
- 2.1.2 Boston Scientific Major Business
- 2.1.3 Boston Scientific Everolimus Eluting Stent Product and Services
- 2.1.4 Boston Scientific Everolimus Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Boston Scientific Recent Developments/Updates
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott Everolimus Eluting Stent Product and Services
- 2.2.4 Abbott Everolimus Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Abbott Recent Developments/Updates
3 Competitive Environment: Everolimus Eluting Stent by Manufacturer
- 3.1 Global Everolimus Eluting Stent Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Everolimus Eluting Stent Revenue by Manufacturer (2020-2025)
- 3.3 Global Everolimus Eluting Stent Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Everolimus Eluting Stent by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Everolimus Eluting Stent Manufacturer Market Share in 2024
- 3.4.3 Top 6 Everolimus Eluting Stent Manufacturer Market Share in 2024
- 3.5 Everolimus Eluting Stent Market: Overall Company Footprint Analysis
- 3.5.1 Everolimus Eluting Stent Market: Region Footprint
- 3.5.2 Everolimus Eluting Stent Market: Company Product Type Footprint
- 3.5.3 Everolimus Eluting Stent Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Everolimus Eluting Stent Market Size by Region
- 4.1.1 Global Everolimus Eluting Stent Sales Quantity by Region (2020-2031)
- 4.1.2 Global Everolimus Eluting Stent Consumption Value by Region (2020-2031)
- 4.1.3 Global Everolimus Eluting Stent Average Price by Region (2020-2031)
- 4.2 North America Everolimus Eluting Stent Consumption Value (2020-2031)
- 4.3 Europe Everolimus Eluting Stent Consumption Value (2020-2031)
- 4.4 Asia-Pacific Everolimus Eluting Stent Consumption Value (2020-2031)
- 4.5 South America Everolimus Eluting Stent Consumption Value (2020-2031)
- 4.6 Middle East & Africa Everolimus Eluting Stent Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Everolimus Eluting Stent Sales Quantity by Type (2020-2031)
- 5.2 Global Everolimus Eluting Stent Consumption Value by Type (2020-2031)
- 5.3 Global Everolimus Eluting Stent Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Everolimus Eluting Stent Sales Quantity by Application (2020-2031)
- 6.2 Global Everolimus Eluting Stent Consumption Value by Application (2020-2031)
- 6.3 Global Everolimus Eluting Stent Average Price by Application (2020-2031)
7 North America
- 7.1 North America Everolimus Eluting Stent Sales Quantity by Type (2020-2031)
- 7.2 North America Everolimus Eluting Stent Sales Quantity by Application (2020-2031)
- 7.3 North America Everolimus Eluting Stent Market Size by Country
- 7.3.1 North America Everolimus Eluting Stent Sales Quantity by Country (2020-2031)
- 7.3.2 North America Everolimus Eluting Stent Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Everolimus Eluting Stent Sales Quantity by Type (2020-2031)
- 8.2 Europe Everolimus Eluting Stent Sales Quantity by Application (2020-2031)
- 8.3 Europe Everolimus Eluting Stent Market Size by Country
- 8.3.1 Europe Everolimus Eluting Stent Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Everolimus Eluting Stent Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Everolimus Eluting Stent Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Everolimus Eluting Stent Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Everolimus Eluting Stent Market Size by Region
- 9.3.1 Asia-Pacific Everolimus Eluting Stent Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Everolimus Eluting Stent Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Everolimus Eluting Stent Sales Quantity by Type (2020-2031)
- 10.2 South America Everolimus Eluting Stent Sales Quantity by Application (2020-2031)
- 10.3 South America Everolimus Eluting Stent Market Size by Country
- 10.3.1 South America Everolimus Eluting Stent Sales Quantity by Country (2020-2031)
- 10.3.2 South America Everolimus Eluting Stent Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Everolimus Eluting Stent Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Everolimus Eluting Stent Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Everolimus Eluting Stent Market Size by Country
- 11.3.1 Middle East & Africa Everolimus Eluting Stent Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Everolimus Eluting Stent Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Everolimus Eluting Stent Market Drivers
- 12.2 Everolimus Eluting Stent Market Restraints
- 12.3 Everolimus Eluting Stent Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Everolimus Eluting Stent and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Everolimus Eluting Stent
- 13.3 Everolimus Eluting Stent Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Everolimus Eluting Stent Typical Distributors
- 14.3 Everolimus Eluting Stent Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Everolimus Eluting Stent. Industry analysis & Market Report on Everolimus Eluting Stent is a syndicated market report, published as Global Everolimus Eluting Stent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Everolimus Eluting Stent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
